Skip to main content
SpringerLink
Log in

Bronchospasmolytika und Antiasthmatika

  • Chapter
Arzneiverordnungs-Report 2001

Zusammenfassung

Bronchospasmolytika werden zur Behandlung des Asthma bronchiale und der chronisch-obstruktiven Bronchitis (COPD) eingesetzt. Bei beiden Erkrankungen ist es das Ziel, die reversible Bronchialobstruktion zu beseitigen und das typische Spätstadium der COD mit Ateminsuffizienz und des Cor pulmonale so weit wie möglich zu bessern.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 44.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 59.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  • Agertoft L., Pedersen S. (2000): Effect of long-term treatment with inhaled budesonide on adult height in children with asthma. N. Engl. J. Med. 343:1064–1069.

    Article  PubMed  CAS  Google Scholar 

  • Arzneimittelkommission der deutschen Ärzteschaft (2000): Arzneiverordnungen. 19. Aufl., Deutscher Ärzte-Verlag, Köln, S. 516–531.

    Google Scholar 

  • Barnes P.J. (1995): Beta-adrenergic receptors and their regulation. Am. J. Respir. Crit. Care Med. 152: 838–860.

    PubMed  CAS  Google Scholar 

  • Barnes P.J., Pauwels R.A. (1994): Theophylline in the management of asthma: time for reappraisal? Eur. Respir. J. 7: 579–591.

    Article  PubMed  CAS  Google Scholar 

  • Buhl R., Kardos P., Magnussen H., Matthys H., Sauer R., Schauer P. et al. (1999): Feste Kombination inhalierbarer Kortikoide und langwirkender ß2-Sympathomimetika zur Langzeittherapie des Asthma bronchiale. Pneumologie 53: 210–212.

    PubMed  CAS  Google Scholar 

  • Bundesgesundheitsamt (1988): Aufbereitungsmonographie zu Cromoglicinsäure. Bundesanzeiger 40 vom 11.7.1998, S. 7–9.

    Google Scholar 

  • Clarke P.S., Ratowsky D.A. (1990): Effect of fenoterol hydrobromide and sodium cromoglycate individually and in combination on postexercise asthma. Ann. Allergy 64 (2 Pt. 2): 187–190.

    PubMed  CAS  Google Scholar 

  • Crout J.R. (1974): Fixed combination prescription drugs: FDA policy. J. Clin. Pharmacol. 14: 249–254.

    PubMed  CAS  Google Scholar 

  • Cumming R.G., Mitchell P., Leeder S.R. (1997): Use of inhaled corticosteroids and the risk of cataracts. New Engl. J. Med. 337: 8–14.

    Article  PubMed  CAS  Google Scholar 

  • Debelic M., Hertel G., König J. (1988): Double-blind crossover study comparing sodium cromoglycate, reproterol, reproterol plus sodium cromoglycate, and placebo in exercise-induced asthma. Ann. Allergy 61: 25–29.

    PubMed  CAS  Google Scholar 

  • Drazen J.M., Israel E., O’Byrne P.M. (1999): Treatment of asthma with drugs modifying the leukotrien pathway. N. Engl. J. Med. 340:197–206.

    Article  PubMed  CAS  Google Scholar 

  • Ducharme F.M., Hicks G.C. (2001): Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma. The Cochrane Library, Issue 2. Oxford: Update Software.

    Google Scholar 

  • Easton P.A., Jadue C., Dhingra S., Anthonisen N.R. (1986): A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in sequence. N. Engl. J. Med. 315: 735–739.

    Article  PubMed  CAS  Google Scholar 

  • Gehrke I., Bohm E., Sybrecht G.W. (1986): Stress-induced asthma - placebo-controlled double-blind comparison of prevention using fenoterol, disodium cromoglycate and a combination of the two. Prax. Klin. Pneumol. 40:129–134.

    PubMed  CAS  Google Scholar 

  • Grahnén A., Eckernas S.A., Brundin R.M., Ling-Andersson A. (1994): An assessment of the systemic activity of single doses of inhaled fluticasone propionate in healthy volunteers. Br. J. Clin. Pharmacol. 38: 521–525.

    Article  PubMed  Google Scholar 

  • Gross N.J. (1988): Ipratropium bromide. N. Engl. J. Med. 319:486–494.

    Article  PubMed  CAS  Google Scholar 

  • Hanania N.A., Chapman K.R., Sturtridge W.C., Szalai J.P., Kesten S. (1995): Dose-related decrease in bone density among asthmatic patients treated with inhaled corticosteroids. J. Allergy Clin. Immunol. 96: 571–579.

    Article  PubMed  CAS  Google Scholar 

  • Jarvis B., Markham A. (2000): Montelukast - a review of its therapeutic potential in persistent asthma. Drugs 59: 891–928.

    Article  PubMed  CAS  Google Scholar 

  • Lemmer B. (1990): Chronopharmakologische Aspekte der Theophyllintherapie. In: Blume H. (Hrsg.): Bioäquivalenz retardierter Theophyllin-Fertigarzneimittel. Govi, Frankfurt, S. 75–82.

    Google Scholar 

  • Lemmer B., Wettengel R. (2001): Erkrankungen der Atemwege. In: Lemmer B., Brune K. (Hrsg.): Pharmakotherapie - Klinische Pharmakologie. 11. Aufl., Urban & Fischer Verlag, München, S. 313–329.

    Google Scholar 

  • Lipworth B.J. (1999): Modern drug treatment of chronic asthma. Brit. Med. J. 318: 380–383.

    Article  PubMed  CAS  Google Scholar 

  • Markham A., Jarvis B. (2000): Inhaled salmeterol/fluticasone propionate combination: a review of its use in persistent asthma. Drugs 60:1207–1233.

    Article  PubMed  CAS  Google Scholar 

  • McCowan C., Neville R.G., Thomas G.E., Crombie I.K., Clark R.A. et al. (1998): Effect of asthma and its treatment on growth: four year follow up of cohort of children from general practices in Tayside, Scotland. Brit. Med. J. 316: 668–672.

    Article  PubMed  CAS  Google Scholar 

  • National Heart, Lung, and Blood Institute (1997): Expert Panel Report 2: Guidelines for the Diagnosis and Management of Asthma [EPR-2]. National Institutes of Health, pub. no. 97–4051.

    Google Scholar 

  • Parfitt K. (1999): Martindale. The complete drug reference. 32nd ed. Pharmaceutical Press, London, pp. 765–774.

    Google Scholar 

  • Robinson D.S., Campbell D., Barnes P.J. (2001): Addition of leukotriene antagonists to therapie in chronic persistent asthma: a randomised doubleblind placebo-controlled trial. Lancet 357: 2007–2011.

    Article  PubMed  CAS  Google Scholar 

  • Rodrigo G., Rodrigo C., Burschtin O. (1999): A meta-analysis of the effects of ipratropium bromide in adults with acute asthma. Am. J. Med. 107: 363–370.

    Article  PubMed  CAS  Google Scholar 

  • Schmidt H. (1994): Retardtheophyllin ist nicht gleich Retardtheophyllin. Atemwegs-Lungenkr. 20: 223–231.

    Google Scholar 

  • Sears M.R., Rea H.H., Fenwick J., Gillies A.J.D., Holst P.E. et al. (1987): 75 Deaths in asthmatics prescibed home nebulisers. Brit. Med. J. 294:477–480.

    Article  CAS  Google Scholar 

  • Serafin W.E. (1996): Drugs used in the treatment of asthma. In: Hardman J.H., Limbird L.E., Molinoff P.B., Ruddon R.W., Goodman Gilman A. (eds.): Goodman & Gilman The Pharmacological Basis of Therapeutics, 9th ed. McGraw Hill, New York, pp. 659–682.

    Google Scholar 

  • Smolensky M.H., D’Alonso G.E. (1997): Progress in the chronotherapy of nocturnal asthma. In: Redfern P., Lemmer B. (eds.): Physiology and Pharmacology of Biological Rhythms. Handbook of Experimental Pharmacology, Vol. 125, Springer, Berlin, Heidelberg, New York, pp. 205–249.

    Chapter  Google Scholar 

  • The Childhood Asthma Management Program Research Group (2000): Long-term effects of budesonide or nedocromil in children with asthma. N. Engl. J. Med. 343:1054–1063.

    Article  Google Scholar 

  • Weinberger M., Hendeles L. (1996): Theophylline in asthma. N. Engl. J. Med. 334: 1380–1388.

    Article  PubMed  CAS  Google Scholar 

  • Wettengel R., Berdel D., Hofmann D., et al. (1998): Asthmatherapie bei Kindern und Erwachsenen. Empfehlungen der Deutschen Atemwegsliga in der Deutschen Gesellschaft für Pneumologie. Med. Klinik 93: 639–650.

    Article  CAS  Google Scholar 

  • Wettengel R. (1999): Zum Kataraktrisiko durch inhalative Kortikoide. Pneumologie 53: 409–410.

    Article  PubMed  CAS  Google Scholar 

  • Williams M.H. (1989): Increasing severity of asthma from 1960 to 1987. N. Engl. J. Med. 320:1015–1020.

    Article  PubMed  Google Scholar 

  • Wohl M.E.B., Majzoub J.A. (2000): Asthma, steroids, and growth. N. Engl. J. Med. 343: 1113–1114.

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. Björn Lemmer
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Pharmakologisches Institut der Universität Heidelberg, Im Neuenheimer Feld 366, 69120, Heidelberg, Germany

    Ulrich Schwabe

  2. Bachstraße 29, 50858, Köln, Germany

    Dieter Paffrath

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Lemmer, B. (2001). Bronchospasmolytika und Antiasthmatika. In: Schwabe, U., Paffrath, D. (eds) Arzneiverordnungs-Report 2001. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56434-5_19

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56434-5_19

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42079-8

  • Online ISBN: 978-3-642-56434-5

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation